POLARAMINE 5 mg/1 ml
Sponsors
Rheacell GmbH & Co. KG, Hopital Fondation Adolphe De Rothschild
Conditions
Myasthenia gravisRecessive Dystrophic Epidermolysis Bullosa(RDEB) and Junctional Epidermolysis Bullosa (JEB)
Phase 3
A double-blind, randomized, placebo-controlled, interventional, multicenter, phase III clinical trial to investigate the safety and efficacy of ABCB5-positive mesenchymal stromal cells (ABCB5+ MSCs) on epidermolysis bullosa (EB)
RecruitingCTIS2022-500266-10-00
Start: 2023-06-13Target: 119Updated: 2025-12-02
Immediate corticosteroid therapy and rituximab to prevent generalization in ocular myasthenia gravis: a PROBE-type multicenter, open-label, randomized controlled trial
RecruitingCTIS2023-506656-24-00
Start: 2025-02-12Target: 128Updated: 2025-06-06